HDR brachytherapy as monotherapy or a boost for high risk prostate cancer: 5 year single center data

被引：0
|
作者：
Novikov, S. [1 ]
Kanaev, S. [1 ]
Novikov, R. [1 ]
Ilin, N. [1 ]
Gotovchikova, M. [1 ]
Girshovitch, M. [1 ]
机构：
[1] NN Petrov Res Natl Med Canc Ctr, Radiotherapy, St Petersburg, Russia
来源：
RADIOTHERAPY AND ONCOLOGY | 2021年 / 158卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-0243
引用
收藏
页码：S202 / S203
页数：2
相关论文
共 50 条
  • [1] HDR brachytherapy as monotherapy for low and intermediate risk prostate cancer
    Gaudet, M.
    Pharand-Charbonneau, M.
    Wright, D.
    Desrosiers, M.
    Haddad, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S1188 - S1188
  • [2] HDR monotherapy brachytherapy for localised prostate cancer
    Hoskin, P. J.
    Bownes, P.
    Bryant, L.
    Ostler, P.
    [J]. CLINICAL ONCOLOGY, 2007, 19 (03) : S7 - S7
  • [3] Outcomes following HDR Brachytherapy Boost for High Risk Localised Prostate Cancer: Data from a UK Centre
    Lorimer, C.
    Ravi, B.
    Cowtan, F.
    Johns, A.
    Robinson, A.
    Nikapota, A.
    [J]. CLINICAL ONCOLOGY, 2023, 35 (02) : E241 - E241
  • [4] SINGLE FRACTION HDR BRACHYTHERAPY AS ANTICIPATED BOOST IN LOCALIZED PROSTATE CANCER
    Cerrotta, A.
    Fallai, C.
    Carrara, M.
    Borroni, M.
    Villa, S.
    Bedini, N.
    Garcia, M.
    Maucione, A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S288 - S289
  • [5] Single dose high dose-rate (HDR) brachytherapy as monotherapy for localised prostate cancer
    Tharmalingam, H.
    Tsang, Y. M.
    Hoskin, P.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S337 - S337
  • [6] HDR brachytherapy for high-risk prostate cancer
    Lo, TCM
    Bouyounes, BT
    Goodman, N
    Bihrle, W
    Roth, RA
    [J]. CANCER JOURNAL, 2001, 7 (06): : 527 - 527
  • [7] Results of high dose rate (HDR) brachytherapy boost for prostate cancer
    Kelly, D
    Flynn, J
    Brookover, W
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S18 - S18
  • [8] HDR brachytherapy as a boost for intermediate and high risk prostate cancer: Longterm outcome of 2028 implants
    Kurek, R
    Martin, T
    Buhleier, T
    Dannenberg, T
    Baltas, D
    Zamboglou, N
    Tunn, UW
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 314 - 314
  • [9] What is the proper dose in single fraction HDR brachytherapy as monotherapy for prostate cancer?
    Ruiz Arrebola, S.
    Tornero-Lopez, A. M.
    De la Vega, J. M.
    Prada, P. J.
    Guirado, D.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S972 - S973
  • [10] HDR Brachytherapy boost irradiation in the radiotherapy (RT) of intermediate and high risk localised prostate cancer
    Agoston, P
    Major, T
    Somogyi, A
    Baricza, K
    Szasz, K
    Lövey, J
    Németh, G
    Kasler, M
    Fodor, J
    [J]. RADIOTHERAPY AND ONCOLOGY, 2005, 75 : S4 - S5
12345